Clinical Trial Update: Repositioning Immunotherapy in VetArans With Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update noting recruitment for a repositioned immunotherapy approach in veterans with non-small cell lung cancer. The trial is sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: VA Office of Research and Development | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: RECRUITING